We don’t formulate products.
We engineer clinical outcomes.
64 clinical-grade protocols. Every active concentration published. Every mechanism of action documented. Full ingredient transparency as standard.
What We Publish. What Others Don't.
Published Concentrations
Every active agent concentration documented on every protocol.
Named Active Architectures
Branded formulation systems with defined mechanisms of action.
pH-Specified Formulations
Exact pH ranges published for predictable penetration depth.

Named Formulation Systems
Every Prodermic protocol is built around a named formulation system — a branded methodology that defines the mechanism, the active architecture, and the clinical endpoint.
Quad-Pathway Depigmentation™
Four active agents attacking melanin synthesis at different biochemical points. Tyrosinase inhibition. Melanin transfer disruption. Epidermal turnover acceleration. Antioxidant conversion.
View Protocol →Carbon Detox Architecture™
Activated carbon matrix combined with a controlled acid delivery system. Deep-pore adsorption. Sebum normalization. Toxin clearance without compromising barrier integrity.
View Protocol →Master Antioxidant Protocol™
Glutathione-led eumelanin-to-pheomelanin conversion supported by multi-acid synergy. The body's master antioxidant, deployed at clinical concentrations.
View Protocol →Dual-Keratolytic System™
Two lipophilic keratolytic agents working in concert. Comedolytic action meets antibacterial efficacy. Resorcinol + Salicylic Acid in calibrated proportions for inflammatory and non-inflammatory acne.
View Protocol →Controlled-Depth Resurfacing™
Precision TCA delivery with acid modulation buffer. Controlled frosting endpoints. Predictable depth penetration for dermal remodeling in experienced hands.
View Protocol →Retinoid Multi-Pathway Architecture™
Seven-agent retinoid system combining retinol with phytic, lactic, and salicylic acids. Controlled epidermal turnover without aggressive peeling. Anti-aging with minimal downtime.
View Protocol →Gentle Quad-Acid Correction™
Four-acid depigmentation system calibrated for sensitive Fitzpatrick IV–VI skin. Glycolic-lactic-citric-kojic synergy at conservative concentrations for melasma without barrier compromise.
View Protocol →Rapid Radiance Architecture™
Three-agent instant glow system. Glycolic-lactic exfoliation paired with arginine vasodilation for immediate luminosity. Zero downtime. Pre-event protocol.
View Protocol →Glycolic-Antioxidant Fusion™
Glycolic acid resurfacing combined with L-Ascorbic Acid antioxidant defense and niacinamide barrier support. Dual-action brightening through exfoliation and oxidative protection.
View Protocol →Keto-Acid Scar Architecture™
Pyruvic-lactic dual keto-acid system for controlled dermal remodeling. Medium-depth penetration targeting atrophic scarring and photodamage with predictable frosting endpoints.
View Protocol →How Multi-Pathway Formulations Work
Using the 580 Yellow Peel as an example — four biochemical pathways working in concert to address hyperpigmentation from multiple angles simultaneously.
Tyrosinase Inhibition
Blocks the enzyme responsible for melanin production at the source.
Melanin Transfer Disruption
Prevents synthesized melanin from reaching the skin surface.
Epidermal Turnover
Accelerates removal of existing pigmented cells from the epidermis.
Antioxidant Conversion
Converts dark eumelanin to lighter pheomelanin.
Clinical Validation
Standardized photography. Controlled protocols. Measurable outcomes across Fitzpatrick III–V skin types.












All patients provided informed consent for photography. Images unedited except standard color calibration. Individual outcomes depend on compliance, skin type, and condition severity.
Manufacturing Standards
Every protocol is manufactured under pharmaceutical-grade conditions with full regulatory compliance and batch traceability.
GMP Certified
Good Manufacturing Practice certified production facility with controlled environments.
ISO 9001:2015
Quality management system certified across formulation, production, and distribution.
DCGI Registered
Drug Controller General of India registered. Full regulatory compliance.
Stability Tested
24-month accelerated stability testing on every formulation before release.
pH Documented
Exact pH ranges published for every protocol. Predictable penetration depth.
Certificate of Analysis
Batch-level COA available on request for every shipment.
Access the complete protocol library.
64 clinical-grade formulations with full ingredient transparency. Every concentration published. Every protocol documented.
